Delivery Order SPE2DR25D1007-SPE2DR26FY8VC
- Not listed
- The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $22,874.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 7, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026, with performance occurring at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract represents a firm fixed price delivery order with a completion date of June 23, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,074.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,157.68 on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive, firm fixed-price delivery order is set to be completed by December 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,494.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on December 14, 2025, with an ultimate completion date of December 15, 2025. This non-competitive, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,086.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. Performance will be completed by January 15, 2026, with fulfillment occurring at the company's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DR25D1007Indefinite Delivery Contract
- SPE2DR25D1007-SPE2DR26FY8VCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,812.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on January 14, 2026. This is a firm fixed-price, non-set-aside delivery order with a completion date of January 15, 2026, to be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor, maintains a significant role in the federal medical supply chain, particularly for Department of Defense and military healthcare systems. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's continued participation in meeting critical pharmaceutical needs for federal military and veteran healthcare programs through competitive federal procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/13/26 |